Molecular Endocrinology, Vol 6, 2090-2102, Copyright © 1992 by Endocrine Society

ARTICLES

Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness

DL Bellingham, M Sar and JA Cidlowski
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill 27599.

The effect of glucocorticoids on the regulation of stably transfected human glucocorticoid receptors has been examined. Exposure of a Chinese hamster ovary-derived cell line containing stably transfected human glucocorticoid receptor genes and glucocorticoid-responsive dihydrofolate reductase genes to 5 nM dexamethasone resulted in a rapid, time-dependent reduction in the level of glucocorticoid receptor protein to 50% of control levels within 5 h of steroid treatment. This decrease in receptor protein was persistent, with a maximal 70% reduction observed even after 4 weeks of dexamethasone treatment. Immunocytochemical analysis of the influence of dexamethasone on stably transfected glucocorticoid receptors revealed efficient translocation of receptors to the nucleus within 1 h of hormone treatment. However, upon longer exposure to dexamethasone (5 h), immunoreactive glucocorticoid receptors were localized primarily to the cytoplasm. By 24 h of treatment, glucocorticoid receptors were absent from the cytoplasm and the nucleus, suggesting that the ligand-induced loss of glucocorticoid receptors may be a cytoplasmic event. The decrease in transfected glucocorticoid receptor protein was largely reflected by similar changes in steady state levels of human glucocorticoid receptor mRNA; however, the effects of hormone on receptor protein levels were more profound than on receptor mRNA. There was an initial rapid reduction in transfected glucocorticoid receptor mRNA to 50% of control levels within 2 h of dexamethasone treatment. This reduction was followed by a transient rise in mRNA expression after 12 h of hormone treatment. With prolonged exposure to dexamethasone (> 12 h) a second, more gradual decline in human glucocorticoid receptor mRNA was observed. This biphasic pattern of glucocorticoid receptor gene expression was not reflected at the level of receptor protein, suggesting that both transcriptional and translational control mechanisms may be involved in ligand-dependent receptor regulation. When cells were removed from dexamethasone after up to 48 h of treatment, glucocorticoid receptor mRNA levels fully recovered within 12 h. Receptor protein recovered only partially during this same time period. Down-regulation of glucocorticoid receptor protein and mRNA levels by dexamethasone in stably transfected cells led to corresponding reductions in the hormone sensitivity to two glucocorticoid-regulated genes: a transiently transfected chloramphenicol acetyltransferase receptor gene and a stably integrated dihydrofolate reductase gene. These results demonstrate that stably transfected human glucocorticoid receptors are subject to ligand- induced down-regulation in a heterologous cell line. Moreover, glucocorticoid receptor autoregulation appears to be a highly conserved mechanism for attenuating cellular responsiveness to hormone.

This article has been cited by other articles:

				H. Kang, Y. S. Kim, and J. Ko A Novel Isoform of Human LZIP Negatively Regulates the Transactivation of the Glucocorticoid Receptor Mol. Endocrinol., November 1, 2009; 23(11): 1746 - 1757. [Abstract] [Full Text] [PDF]

				Z. Khan, S. Vijayakumar, T. V. de la Torre, S. Rotolo, and A. Bafico Analysis of Endogenous LRP6 Function Reveals a Novel Feedback Mechanism by Which Wnt Negatively Regulates Its Receptor Mol. Cell. Biol., October 15, 2007; 27(20): 7291 - 7301. [Abstract] [Full Text] [PDF]

				M. Schupp, M. Clemenz, R. Gineste, H. Witt, J. Janke, S. Helleboid, N. Hennuyer, P. Ruiz, T. Unger, B. Staels, et al. Molecular Characterization of New Selective Peroxisome Proliferator-Activated Receptor {gamma} Modulators With Angiotensin Receptor Blocking Activity Diabetes, December 1, 2005; 54(12): 3442 - 3452. [Abstract] [Full Text] [PDF]

				Y. S. Kim, S.-W. Jang, H. J. Sung, H. J. Lee, I. S. Kim, D. S. Na, and J. Ko Role of 14-3-3{eta} as a Positive Regulator of the Glucocorticoid Receptor Transcriptional Activation Endocrinology, July 1, 2005; 146(7): 3133 - 3140. [Abstract] [Full Text] [PDF]

				X. Wang and D. B. DeFranco Alternative Effects of the Ubiquitin-Proteasome Pathway on Glucocorticoid Receptor Down-Regulation and Transactivation Are Mediated by CHIP, an E3 Ligase Mol. Endocrinol., June 1, 2005; 19(6): 1474 - 1482. [Abstract] [Full Text] [PDF]

				X. Wang, J. L. Pongrac, and D. B. DeFranco Glucocorticoid Receptors in Hippocampal Neurons that Do Not Engage Proteasomes Escape from Hormone-Dependent Down-Regulation but Maintain Transactivation Activity Mol. Endocrinol., September 1, 2002; 16(9): 1987 - 1998. [Abstract] [Full Text] [PDF]

				D. B. DeFranco Navigating Steroid Hormone Receptors through the Nuclear Compartment Mol. Endocrinol., July 1, 2002; 16(7): 1449 - 1455. [Abstract] [Full Text] [PDF]

				B. J. Deroo, C. Rentsch, S. Sampath, J. Young, D. B. DeFranco, and T. K. Archer Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking Mol. Cell. Biol., June 15, 2002; 22(12): 4113 - 4123. [Abstract] [Full Text] [PDF]

				A. D. Wallace and J. A. Cidlowski Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids J. Biol. Chem., November 9, 2001; 276(46): 42714 - 42721. [Abstract] [Full Text] [PDF]

				M. R. Yudt and J. A. Cidlowski Molecular Identification and Characterization of A and B Forms of the Glucocorticoid Receptor Mol. Endocrinol., July 1, 2001; 15(7): 1093 - 1103. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				J. Liu and D. B. DeFranco Protracted Nuclear Export of Glucocorticoid Receptor Limits Its Turnover and Does Not Require the Exportin 1/CRM1-Directed Nuclear Export Pathway Mol. Endocrinol., January 1, 2000; 14(1): 40 - 51. [Abstract] [Full Text]

				R. J Hancox, D. A Stevens, I. M Adcock, P. J Barnes, and D R. Taylor Effects of inhaled beta  agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma Thorax, June 1, 1999; 54(6): 488 - 492. [Abstract] [Full Text]

				S. Boronat, H. Richard-Foy, and B. Pina Specific Deactivation of the Mouse Mammary Tumor Virus Long Terminal Repeat Promoter upon Continuous Hormone Treatment J. Biol. Chem., August 29, 1997; 272(35): 21803 - 21810. [Abstract] [Full Text] [PDF]

				R. Yehuda, D. Boisoneau, M. T. Lowy, and E. L. Giller Jr Dose-Response Changes in Plasma Cortisol and Lymphocyte Glucocorticoid Receptors Following Dexamethasone Administration in Combat Veterans With and Without Posttraumatic Stress Disorder Arch Gen Psychiatry, July 1, 1995; 52(7): 583 - 593. [Abstract] [PDF]

				M. W. Dudley, C. Q. Sheeler, H. Wang, and S. Khan Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: Implications for their mechanism of action PNAS, March 28, 2000; 97(7): 3696 - 3701. [Abstract] [Full Text] [PDF]